BridgeBio Pharma Inc annual earnings per share (EPS) for fiscal TTM was $-3.58, an increase of 3.2% from $-3.70 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| EPS (annual) | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-3.58 | $-3.70 | $-2.88 | $-3.95 | $-3.26 | $-3.90 | $-3.80 | $-2.48 | $-1.42 | $-0.33 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| EPS (quarterly) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (EPS) | $-0.78 | $-0.84 | $-1.00 | $-0.96 | $-0.95 | $-0.88 | $-1.40 | $-0.86 | $-0.39 |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More BBIO metrics: Revenue · Gross Profit · Operating Income · Net Income · EBITDA · Free Cash Flow · Shares Outstanding
All BBIO financial statements → Interactive BBIO charts →
About TickerBase · Data methodology & sources · Privacy · Terms